Keyphrases
Breast Cancer Patients
100%
Prognostic Value
100%
Plasminogen Activator inhibitor-1 (PAI-1)
100%
Angiogenesis
100%
Breast Cancer
18%
Prognostic Marker
18%
Overall Survival
18%
Prognostic Impact
18%
Recurrence-free Survival
18%
Hazard Ratio
9%
Cell Culture
9%
Follow-up Time
9%
Multivariate Analysis
9%
Risk of Death
9%
Microvessels
9%
Invasive Breast Cancer
9%
Tumor Angiogenesis
9%
Recurrence Risk
9%
CD34
9%
Angiogenic
9%
Tumor Extract
9%
Primary Breast Cancer
9%
Proteinase
9%
Counting Method
9%
Short-term Recurrence
9%
Animal Model System
9%
Immunology and Microbiology
Angiogenesis
100%
Overall Survival
50%
Recurrence Free Survival
50%
Monospecific Antibody
25%
ELISA
25%
Cell Culture
25%
CD34
25%
Tumor Extract
25%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
100%
Plasminogen Activator Inhibitor-1
100%
Overall Survival
18%
Recurrence Free Survival
18%
Monospecific Antibody
9%
Animal Model
9%
Cell Culture
9%
Multivariate Analysis
9%
CD34
9%
Tumor Extract
9%
Protease
9%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Plasminogen Activator Inhibitor 1
100%
Overall Survival
18%
Recurrence Free Survival
18%
Neoplasm
9%
Recurrent Disease
9%
Enzyme-Linked Immunosorbent Assay
9%
Proteinase
9%
Cell Culture
9%
Tumor Extract
9%